• Create account
  • Log in
Clinical Guidelines
  • Home
  • About
    • About the clinical guidelines
    • Declaring and dealing with competing interests
    • Frequently asked questions
    • Guideline journal articles
  • CCA guidelines
    • Barrett's Oesophagus
    • Bowel cancer
      • Colorectal cancer
      • Surveillance colonoscopy
    • Endometrial cancer
    • Cervical cancer screening
    • Lung cancer
      • Lung cancer prevention & diagnosis
      • Lung cancer treatment
    • Prostate cancer
      • Advanced prostate cancer
      • PSA testing
    • Sarcoma
    • Skin cancer
      • Melanoma
      • Keratinocyte cancer (non-melanoma)
    • Pain management
    • Archive of CCA guidelines
  • COSA guidelines
    • Adolescents and Young Adult (AYA) guidelines
      • AYA cancer fertility preservation
      • AYA early cancer detection
      • AYA psychosocial management
    • Cancer therapy medication safety
    • Gastroenteropancreatic neuroendocrine tumours
    • Head & neck cancer nutrition
    • Teleoncology
  • Hosted
    • Childhood Brain Tumour or Leukaemia
  • National Cancer Prevention Policy
  • View
  • View form
  • Code
  • History
  • Refresh
  • What links here
  • Related changes
  • Special pages
  • Permanent link
  • Page information
  • Browse properties

Citation:Pataky R, Gulati R, Etzioni R, Black P, Chi KN, Coldman AJ, et al 2014

From Cancer Guidelines Wiki
Jump to:navigation, search

Citation


Pataky R, Gulati R, Etzioni R, Black P, Chi KN, Coldman AJ, et al. Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada. Int J Cancer 2014 Aug 15;135(4):939-47 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24443367.



Critical appraisals

  • Assign a critical appraisal


Compare quality appraisals for each clinical question

Cited by

  1. Introduction
  2. PSA Testing strategies
  3. Table 2.2. Modelled outcomes of a range of PSA testing protocols sorted in decreasing order of probability of death from prostate cancer prevented for protocols reported by Pataky et al 2014
  4. Table 2.2. Modelled outcomes of a range of PSA testing protocols sorted in decreasing order of probability of death from prostate cancer prevented for protocols reported by Pataky et al 2014
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Pataky_R,_Gulati_R,_Etzioni_R,_Black_P,_Chi_KN,_Coldman_AJ,_et_al_2014&oldid=96287"
Cancer Council would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.